Table 1.
Patient data (Permissive hypercapnia cohort).
Fig 1.
Blood gas result, ventilation parameters, and number of blood gases of the cohort of immunocompromised children (n = 38) ventilated with allowance of severe hypercapnia.
Dashed line = survivors; solid line = non-survivors. Median and interquartile ranges are given.
Fig 2.
Survival and length of ventilation of a cohort of immunocompromised 38 children exposed to severe permissive hypercapnia.
(A) Survival plot and (B) length of ventilation. Dashed line = survivors; solid line = non-survivors.
Table 2.
Adverse events (Permissive hypercapnia cohort).
Table 3.
Long term outcome (Permissive hypercapnia cohort).
Table 4.
Comparison of the recent permissive hypercapnia period with a historical period.
All admissions of immunocompromised patients to the PICU.
Table 5.
Comparison of the recent permissive hypercapnia period with a historical period.
Patients ventilated ≥24h*.
Fig 3.
Comparison of the permissive hypercapnia period (Cohort A) with a historical period (Cohort B).
(A) Survival plots of all episodes of admission of immunocompromised children to the PICU. (B) Survival plots of immunocompromised children ventilated >24h. Solid line = Permissive hypercapnia cohort; dashed line = historical cohort.